Results 1 - 20 of 320 for All Library Resources
Show only
Refined by:
resource type:
Text Resources
| Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
|---|---|---|---|
| 1 |
Material Type: Text Resource
|
|
1 in 216 Americans Reporting New Infection in Past Week; Bidens Get First Dose of Vaccine on Monday in Delaware. Aired 1-1:30p ETCNN Newsroom, 2020Content and programming copyright 2020 Cable News Network LP, LLLP. ALL RIGHTS RESERVED. Prepared by ASC Services II Media, LLC. No license is granted to the user of this material other than for research. User may not reproduce or redistribute the material except for user's personal or internal use and, in such case, only one copy may be printed, nor shall user use any material for commercial purposes or in any fashion that may infringe upon Cable News Network LP, LLLP's copyright or other proprietary rights or interests in the material; provided, however, that members of the news media may redistribute limited portions (less than 250 words) of this material without a specific license from CNN so long as they provide conspicuous attribution to CNN as the originator and copyright holder of such material. This is not a legal transcript for purposes of litigation.Digital Resources/Online E-Resources |
| 2 |
Material Type: Text Resource
|
|
1 in 3 Adults In The U.S. Take Medications That Can Cause DepressionAll Things Considered, 2018Copyright NPR Jun 12, 2018Digital Resources/Online E-Resources |
| 3 |
Material Type: Text Resource
|
|
Acceleron Pharma Inc Corporate Call - FinalFair Disclosure Wire, 2018COPYRIGHT 2018 CQ-Roll Call, Inc.Digital Resources/Online E-Resources |
| 4 |
Material Type: Text Resource
|
|
Acceleron Pharma Inc STELLAR Phase 3 Trial Design Conference Call - FinalFair Disclosure Wire, 2020COPYRIGHT 2020 CQ-Roll Call, Inc.Digital Resources/Online E-Resources |
| 5 |
Material Type: Text Resource
|
|
Acceleron Pharma Inc to Host Pulmonary Arterial Hypertension Research and Development Deep Dive Event - FinalFair Disclosure Wire, 2018COPYRIGHT 2018 CQ-Roll Call, Inc.Digital Resources/Online E-Resources |
| 6 |
Material Type: Text Resource
|
|
Actelion Ltd Company Update Conference Call - FinalFair Disclosure Wire, 2012COPYRIGHT 2012 CQ-Roll Call, Inc.Digital Resources/Online E-Resources |
| 7 |
Material Type: Text Resource
|
|
Actelion Ltd Macitentan Meets Primary Endpoint in Pivotal Phase III SERAPHIN Outcome Study Conference Call - FinalFair Disclosure Wire, 2012COPYRIGHT 2012 CQ-Roll Call, Inc.Digital Resources/Online E-Resources |
| 8 |
Material Type: Text Resource
|
|
Actelion Ltd US FDA Approval of Opsumit (macitentan) for the Treatment of Pulmonary Arterial Hypertension Conference Call - FinalFair Disclosure Wire, 2013COPYRIGHT 2013 CQ-Roll Call, Inc.Digital Resources/Online E-Resources |
| 9 |
Material Type: Text Resource
|
|
Actelion to Discuss US FDA Approvalof Uptravi (Selexipag) for Thetreatment of Pulmonary Arterial Hypertension Corporate Call - FinalFair Disclosure Wire, 2016COPYRIGHT 2016 CQ-Roll Call, Inc.Digital Resources/Online E-Resources |
| 10 |
Material Type: Text Resource
|
|
African Americans Remain Hardest Hit By Medical BillsMorning Edition, 2013Copyright NPR Jun 10, 2013Digital Resources/Online E-Resources |
| 11 |
Material Type: Text Resource
|
|
Airborne particulate matter (PM2.5) triggers ocular hypertension through pyroptosisParticle and Fibre Toxicology, 20212021. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.21203/rs.3.rs-75533/v1Digital Resources/Online E-Resources |
| 12 |
Material Type: Text Resource
|
|
ALBERTA HEALTH UPDATEPower & Politics, 20202020 Canadian Broadcasting Corporation Rights protected exclusive ownership of the broadcaster. Your licence is limited to a private, internal and non-commercial use of this copy only. Any reproduction, broadcast (including radio and television broadcasting), public performance, transmission, redistribution (including via intranet, Internet or otherwise), distribution to any third party, use in relation to any legal or regulatory procedure, use for any political or promotional purpose or for any other purposes contrary to the law or any other uses of this work is strictly forbidden without the prior written authorization of the broadcaster. ;2021 Canadian Broadcasting Corporation Rights protected exclusive ownership of the broadcaster. Your licence is limited to a private, internal and non-commercial use of this copy only. Any reproduction, broadcast (including radio and television broadcasting), public performance, transmission, redistribution (including via intranet, Internet or otherwise), distribution to any third party, use in relation to any legal or regulatory procedure, use for any political or promotional purpose or for any other purposes contrary to the law or any other uses of this work is strictly forbidden without the prior written authorization of the broadcaster. ;2021 Radio-Canada Droits protégés, propriété exclusive du radiodiffuseur. Votre licence se limite à un usage privé, interne et non commercial ce cette Unique copie. Toute reproduction, diffusion (incluant la radiodiffusion), exécution publique, transmission, redistribution (notamment par un intranet, l'Internet ou autrement), circulation à un tiers, utilisation en rapport avec une procédure légale ou réglementaire, Utilisation à des fins politiques, promotionnelles ou contraires à la loi ou autre utilisation de la présente oeuvre est strictement interdite sans L'autorisation écrite préalable du radiodiffuseur. ;2022 Canadian Broadcasting Corporation Rights protected exclusive ownership of the broadcaster. Your licence is limited to a private, internal and non-commercial use of this copy only. Any reproduction, broadcast (including radio and television broadcasting), public performance, transmission, redistribution (including via intranet, Internet or otherwise), distribution to any third party, use in relation to any legal or regulatory procedure, use for any political or promotional purpose or for any other purposes contrary to the law or any other uses of this work is strictly forbidden without the prior written authorization of the broadcaster.Digital Resources/Online E-Resources |
| 13 |
Material Type: Text Resource
|
|
Alnylam Pharmaceuticals Inc 'RNAi Roundtable" Webcast Series: ALNAGT, in Development for the Treatment of Hypertension - FinalFair Disclosure Wire, 2020COPYRIGHT 2020 CQ-Roll Call, Inc. ;COPYRIGHT 2021 CQ-Roll Call, Inc.Digital Resources/Online E-Resources |
| 14 |
Material Type: Text Resource
|
|
Alnylam Pharmaceuticals Inc Virtual RD Day - FinalFair Disclosure Wire, 2021COPYRIGHT 2021 CQ-Roll Call, Inc.Digital Resources/Online E-Resources |
| 15 |
Material Type: Text Resource
|
|
Alzheimer's Screenings Often Left Out Of Seniors' Wellness ExamsAll Things Considered, 2019Copyright NPR Mar 5, 2019Digital Resources/Online E-Resources |
| 16 |
Material Type: Text Resource
|
|
Analapril Drug For Congestive Heart FailMorning Edition, 1991Copyright NPR Nov 12, 1991Digital Resources/Online E-Resources |
| 17 |
Material Type: Text Resource
|
|
Analysis: Kids' blood pressureMorning Edition, 2004, p.1Copyright 2004Digital Resources/Online E-Resources |
| 18 |
Material Type: Text Resource
|
|
Analysis: Many Americans don't have their high blood pressure under control: 1All Things Considered, 2001, p.1Copyright 2001Digital Resources/Online E-Resources |
| 19 |
Material Type: Text Resource
|
|
Analysis: New studies suggest problems with mitochondria may play a key role in metabolic syndromeAll Things Considered, 2004, p.1(c) 2004 National Public Radio, Inc. All Rights Reserved.Digital Resources/Online E-Resources |
| 20 |
Material Type: Text Resource
|
|
ANALYSIS: NEW STUDY SHOWS HIGH BLOOD PRESSURE WILL EVENTUALLY STRIKE ALMOST EVERYONEAll Things Considered, 2002, p.1Copyright 2002Digital Resources/Online E-Resources |
Results 1 - 20 of 320 for All Library Resources
Personalize your results
Refine Search Results
Expand My Results
Show only
Refine My Results
Creation Date
- Before 1983 (10)
- 1983 To 2003 (17)
- 2004 To 2010 (27)
- 2011 To 2018 (103)
- After 2018 (193)
-
More options
New Records
Subject
- Hypertension (271)
- Blood Pressure (87)
- Medical Research (53)
- Medicine, Experimental (51)
- Diabetes (48)
- Care And Treatment (45)
- Conferences, Meetings And Seminars (45)
- Pulmonary Hypertension (40)
- Health Aspects (36)
- Pharmaceutical Industry (35)
- Risk Factors (30)
- Coronaviruses (27)
- Covid-19 (26)
- Cardiovascular Disease (24)
- Patients (22)
- Obesity (21)
- Clinical Trials (21)
- Pandemics (19)
- Health Care Industry (18)
- Biotechnology Industry (18)
-
More options
Databases
- ProQuest Central (291)
- VCU Scholars Compass (15)
- Coronavirus Research Database (6)
- Recercat (6)
- UKnowledge (2)
- NORA - Norwegian Open Research Archives (2)
- PubMed Central (1)
- GFMER Free Medical Journals (1)
- Vanderbilt University Institutional Repository (1)
- ROAD: Directory of Open Access Scholarly Resources (1)
- Sydney eScholarship Repository (1)
- ERIC - Full Text Only (Discovery) (1)
- U.S. Government Documents (1)
- AUB ScholarWorks (1)
- DOAJ Directory of Open Access Journals (1)
- ScholarWorks @ UVM (1)
-
More options
Language
- English (316)
- Catalan (3)
- French (1)
- Norwegian (1)
-
More options
|
||||
 |
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY |  |
(84-028) 37 755 057 | Feedback |
| 19 Nguyen Huu Tho St. Dist.7, HCM |  |
thuvien@tdtu.edu.vn | ||